The role of an 18th-century instrument maker, Francis Hauksbee the Younger, may have been pivotal in shaping the landscape of modern clinical trials. His contributions possibly influenced James Lind, a Royal Navy surgeon, whose pioneering controlled trial helped identify vitamin C as an effective
The University of Kentucky (UK) researchers are currently engaged in a groundbreaking clinical trial aimed at exploring the potential benefits of medical cannabis in managing symptoms of late-stage dementia. This study, officially named the LiBBY Study, is backed by both the National Institutes of
In York, a family's journey of resilience and gratitude has culminated in a remarkable fundraising achievement for Cancer Research UK. The Burn family, inspired by their mother's successful battle against cancer, transformed their personal trials into a community-driven mission to support the
3D bioprinting is an innovative technology that promises to revolutionize cancer research and treatment by providing more accurate and complex models of tumor tissue. This advancement is particularly significant in the study of cancers involving the BRCA1 gene. Tumor modeling with 3D bioprinting
The transformative impact of a historic AI infrastructure investment on the drug discovery and healthcare sectors is becoming increasingly evident. This $500 billion investment, spearheaded by Stargate—a collaborative venture between OpenAI, SoftBank, and Oracle—aims to fast-track breakthroughs in
BeiGene Ltd., one of China's foremost developers of next-generation cancer drugs, is on the cusp of turning a profit after years of significant investments in research and development. The company has made remarkable strides towards achieving an annual operating profit, bolstered by the successful
